Tom Schewe Stripped of Bordeaux World Cup Podium Following Positive Medication Test

A career-defining moment has turned into a costly lesson for German showjumping rider Tom Schewe. The 27-year-old athlete has been stripped of his third-place finish, prize money, and ranking points from the World Cup stage in Bordeaux after his horse, Congress Blue PS, tested positive for a prohibited medication.

The announcement, released by the Fédération Équestre Internationale (FEI), effectively erases what was described as Schewe’s greatest international success to date. Riding the nine-year-old gelding Congress Blue PS, Schewe had secured a sensational podium spot in early February, finishing third behind Jessica Burke and Daniel Deusser after a double-clear performance in the jump-off.

The Substance: Understanding 3-Hydroxydetomidine

The medication control conducted after the event revealed the presence of 3-hydroxydetomidine in the horse’s system. For those unfamiliar with equestrian pharmacology, 3-hydroxydetomidine is a metabolite—a breakdown product—of Detomidine. Detomidin is a common veterinary drug used as a sedative, anesthetic, and analgesic, often employed in the treatment of severe conditions such as colic.

Crucially, the FEI classifies this substance under “Controlled Medication” rather than as a prohibited doping agent. While the drug is legal for veterinary treatment, it must be completely cleared from the horse’s system before they enter a competition. The rules regarding clearance, known as the withdrawal period, vary by governing body:

• FEI: Specifies a withdrawal period of 48 hours.
• FN (Deutsche Reiterliche Vereinigung): Lists the drug as prohibited in competition with a longer withdrawal period of six days.

Despite the clear rules, Schewe stated that he has no explanation for how the substance entered his horse’s organism.

Financial and Competitive Fallout

The repercussions of the positive test are significant, both financially and in terms of professional standing. Because the result has been annulled, Schewe is required to return the prize money earned from his third-place finish.

The total financial hit includes:

• Prize Money Repayment: €34,500
• FEI Fine: 1,500 Swiss Francs (CHF)
• Procedural Costs: 2,000 Swiss Francs (CHF)

Beyond the monetary loss, the competitive blow is equally heavy. Schewe loses the 15 World Cup points he gained in Bordeaux, a setback for the Bad Eilsen-based professional and German vice-champion who had used the event to signal his arrival among the world’s elite.

The ‘Fast Track’ Resolution

While the loss of points and money is steep, Schewe avoided a competitive suspension. This was made possible through his agreement to the FEI’s “Fast Track” procedure. This administrative route allows riders to accept the findings and the associated penalties quickly to avoid the lengthy legal process and the potential for a prolonged ban from the sport.

By opting for this procedure, Schewe can continue to compete, although the shadow of the Bordeaux disqualification remains a significant blot on an otherwise rising trajectory.

Key Takeaways from the Ruling

For a rider of Schewe’s caliber, the incident serves as a stark reminder of the strict liability athletes hold over their horses’ medication. In the high-stakes environment of the World Cup circuit, the margin between a career breakthrough and a regulatory disaster is often measured in hours of medication clearance.

The equestrian community now looks toward Schewe’s next outings to see how the German vice-champion bounces back from this professional setback. Official updates regarding his future competition schedule will be released via the FEI calendar.

Do you think the “Fast Track” procedure is a fair way to handle medication errors in equestrian sports? Let us know in the comments.